Cardiovascular

RSS

Genentech claims CHF for heart failure and neurological disorders

Sep. 6, 1996

cGMP PDE inhibitors from Taisho

Sep. 6, 1996

Clinical trials to begin on laser for transmyocardial revascularization

Sep. 6, 1996

Generic nadolol approved

Sep. 6, 1996

CGS-28106 for hypertension and congestive heart failure

Sep. 6, 1996

Zambon selects a dopaminergic compound for evaluation in cardiovascular/renal disorders

Sep. 6, 1996

New angiotensin II antagonists from Kotobuki

Sep. 6, 1996

alpha1-Adrenoceptor blockers with advantages over prazosin

Sep. 6, 1996

Fujisawa discloses vasopressin antagonists

Sep. 6, 1996

CPC-111 clinical trial results disclosed

Aug. 30, 1996